SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Swell

Swell is gaining attention as community members highlight its low market cap and potential for significant growth, particularly with increased volume and its listing on Coinbase. Some users are drawing comparisons to other cryptocurrencies, suggesting Swell could experience a similar surge, while others discuss its liquid staking protocol and upcoming L2 Swell chain. However, some caution against potential risks, pointing to past performance and developer activity.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as community members discuss its recent surge and potential as a privacy-focused alternative to Bitcoin. Bullish sentiment is fueled by speculation about limited supply, increased adoption of shielded addresses, and comparisons to Bitcoin's early days. Concerns about volatility and potential pullbacks are also being weighed as the crypto community assesses ZEC's future.

COTI is a fast and light confidentiality layer on Ethereum. Powered by the breakthrough cryptographic protocol Garbled Circuits and secured by Ethereum, COTI introduces the most advanced and compliant solution for data protection on the public blockchain. Paving the way for the next wave of Web3 innovation and adoption, COTI unlocks a whole new world of use cases, including confidential transactions, Artificial Intelligence, DeFi, decentralized identification, and more.

COTI

COTI is trending as community members highlight its potential within the privacy coin sector, drawing comparisons to established projects like Zcash and Ethereum.  Enthusiasts are actively discussing COTI's underlying technology and anticipating potential catalysts, including the upcoming mainnet launch. There's also broader conversation around AI integration, which has driven chatter surrounding this project.

GALA is designed to power the Gala Games ecosystem to support gaming re-imagined to benefit creators and players, alike.

Gala Games

GALA is trending amid general market optimism, with community members discussing potential price targets and accumulating more coins. Upcoming catalysts related to GalaChain development, game integrations, and expansion into film/music are also circulating. Some users express frustration with the token's performance compared to other cryptocurrencies, while others remain bullish on its long-term potential.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

ICP is trending as the community discusses its potential as a decentralized compute platform and its integration with AI, particularly after the launch of Caffeine AI. Bullish sentiment is fueled by the belief that ICP addresses key limitations in the blockchain space, although some caution against a potential pullback. Discussions also revolve around comparing ICP to other trending cryptocurrencies, such as ZEC.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is trending amid a mix of bullish and bearish sentiment, with some traders anticipating a potential pump while others foresee further declines. Community members are debating whether recent price movements represent a genuine recovery or just another "sucker" rally, with discussions focusing on bag holding and potential future price levels. The conversation also includes mentions of staking rewards and the circulating supply.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

KPTI is trending due to frustration and criticism surrounding its CEO Richard Paulson, with shareholders expressing concerns about value destruction and mismanagement; some are calling for his removal. Despite recent positive analyst ratings and potential catalysts, community sentiment remains largely negative, focusing on the company's financial performance and leadership. The discussion also includes concerns about potential reverse stock splits and the company's future direction.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group ($UNH) is trending due to concerns around potential policy changes impacting healthcare subsidies and direct payments to consumers, sparked by recent political discourse. The community is debating the implications for insurance companies, with some fearing a "bloodbath" while others believe insurers like UNH could benefit from a shift towards individual markets. Discussions also include the impact of weight loss drugs and broader market conditions on UNH's performance.

Vanguard Group, Inc. - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending amidst discussions around potential market impacts from political events and economic indicators. Community members are debating the influence of the current administration's policies, including tariffs, on the economy and job market. The ETF's performance is also being compared to other investment strategies, such as dividend-focused funds, within the context of overall market trends.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

CVM is trending as investors eagerly await news regarding the potential Breakthrough Medicine Designation from the Saudi Food and Drug Authority for its cancer treatment, Multikine. Community discussions revolve around the timeline for the decision, the implications of a potential partnership with Dallah Pharma, and speculation about Ergomed's recent share sales. Amidst the anticipation, there's a broader debate on the company's future prospects and financial stability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

JPMorgan Chase & Co. Cuts CONMED (NYSE:CNMD) Price Target to $52.00

JPMorgan Chase & Co. reduced their target price on CONMED from $58.00 to $52.00 and set a "neutral" rating on the stock in a research note on Thursday...

CONMED (NYSE:CNMD) Hits New 52-Week Low Following Analyst Downgrade

CONMED (NYSE:CNMD) Reaches New 1-Year Low on Analyst Downgrade...

CNMD or MMSI: Which Is the Better Value Stock Right Now?

CNMD vs. MMSI: Which Stock Is the Better Value Option?

CONMED (NYSE:CNMD) Given New $55.00 Price Target at Piper Sandler

Piper Sandler reduced their price objective on shares of CONMED from $68.00 to $55.00 and set an "overweight" rating on the stock in a research note on Thursday...

Wells Fargo & Company Has Lowered Expectations for CONMED (NYSE:CNMD) Stock Price

Wells Fargo & Company lowered their price target on shares of CONMED from $57.00 to $47.00 and set an "equal weight" rating on the stock in a report on Thursday...

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CONMED (NYSE:CNMD) Releases Earnings Results, Beats Expectations By $0.03 EPS

CONMED (NYSE:CNMD - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $1.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of...

CONMED Q3 Earnings and Revenues Beat Estimates, Margins Contract

CNMD beats third-quarter 2025 estimates on strength in surgery segments, but gross and operating margins see sharp contraction.

Compared to Estimates, Conmed (CNMD) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Conmed (CNMD) Tops Q3 Earnings and Revenue Estimates

Conmed (CNMD) delivered earnings and revenue surprises of +2.86% and +0.42%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Conmed Corp.

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

CNMD
Conmed Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CNMD News

CNMDConmed Corp.